A recent clinical publication in a peer-reviewed journal, JCI Insight, offers a practical, noninvasive approach to detect and monitor discrete retinal amyloid deposits in patients using solid-lipid curcumin and a modified scanning laser ophthalmoscope. The researchers conclude that the concept may lead to a practical and feasible approach for large-scale AD diagnosis and monitoring.2
Natural Products INSIDER, October 2016 - Researchers with the Srikot Research Institute studied the effects of Pomella® Extract (from Verdure Sciences) in patients (20-60 years of age) with myocardial infarction in conjunction with regular prescribed medications. The study determined the effects of 300 mg/Pomella twice daily for 30 days on biomedical parameters like HDL, total cholesterol, triglycerides, LDL, non-HDL cholesterol, serum homocysteine, hs-CRP, and OX-LDL as an add-on with regular medication showing improved antioxidant status of the blood biomarkers associated with cardiac health.
JUNE 2017 – Researchers at Central Michigan University have taken a closer look at Longvida® Optimized Curcumin. Previously, these researchers conducted amyloid binding work in vitro with promising results1. Recently published, in the International Journal of Alzheimer’s Disease, Maiti P et al have compared standard, unformulated curcumin more closely to Longvida with SLCP™ Technology.